A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

INTRODUCTION: Radium-223, abiraterone, and enzalutamide have each been shown to significantly improve survival as monotherapy in patients with metastatic castration-resistant prostate cancer. However, effects of combination radium-223 plus abiraterone or enzalutamide on survival and safety remain un...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E., Crona, Daniel J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216516/
https://ncbi.nlm.nih.gov/pubmed/34153052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253021
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg